{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:45:32Z","timestamp":1790793932185,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"30","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2018,9,27]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Adenosine is an endogenous purine nucleoside, which mediates a\nvariety of important biological processes and diseases, such as vasodilation, inflammation,\ncancer, wound healing, ischemia reperfusion injury, Parkinson disease, infectious diseases,\nand other CNS disorders. Particularly important are the A2A receptors that have been expressed\nin the lung, liver, heart, cardiovascular tissues, leukocytes, neutrophils, and endothelial\ncells. This review provides an update of the latest A2A receptor agonists developed in the\nperiod 2005-2017, their selectivity regarding other adenosine receptors and their potential\ntherapeutic applications.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> I have conducted an extensive search from the most common bibliographic databases\nfor critically review the most recent works on the A2A receptor agonists and their therapeutic\napplications in inflammation, asthma and chronic obstructive pulmonary disease, myocardial\nperfusion imaging, sepsis, rheumatoid arthritis, and wound healing, among others.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> In the last decade, a great deal of effort has been devoted to develop adenosine receptor\nagonists and antagonists for treatment of a number of diseases. Thus, for A2A receptor\nagonists more than 130 papers and reviews have been found, many of them highlighting the\nusefulness of these compounds in the field.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p> Although so far many of the A2A receptor agonists have failed in clinical trials\ndue to their side effects, some of them have been approved for protection against cardiac\nischemia-reperfusion injury and anemia. The recently reported crystal structure of the human\nA2A receptor in complex with the agonist UK-432097 is a fundamental keystone for the development\nof new and selective A2A ligands with new therapeutic applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867325666180313110254","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T11:59:39Z","timestamp":1520942379000},"page":"3597-3612","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update"],"prefix":"10.2174","volume":"25","author":[{"given":"Angel","family":"Guerrero","sequence":"first","affiliation":[{"name":"Department of Biological Chemistry and Molecular Modelling, Institute of Advanced Chemistry of Catalonia (CSIC), 08034 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/160408","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/160408\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/160408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T09:48:04Z","timestamp":1608889684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/160408\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":0,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2018,9,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180313110254","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}